Carregant...
Cancer nanomedicine: Is targeting our target?
Nanomedicine may have a delivery problem. Rigorous, realistic and holistic rethinking is needed to improve nanomedicine performance and increase patient benefit.
Guardat en:
| Publicat a: | Nat Rev Mater |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5034892/ https://ncbi.nlm.nih.gov/pubmed/27668091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/natrevmats.2016.69 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|